Prior to joining Stanford University, MaryAnn was the founding director of the Master?s Program in Genetic Counseling and Assistant Dean in the Division of Graduate Medical Sciences at Boston University School of Medicine. Her clinical career has focused on prenatal genetic counseling, serving in that capacity for three years with the Greenwood Genetic Center and 12 years at Boston Medical Center. She has served on national committees for the American Board of Genetic Counseling (ABGC), the Accreditation Council for Genetic Counseling (ACGC), and the Association of Genetic Counseling Program Directors (AGCPD), and she was on the 2015-2017 Board of Directors for the National Society of Genetic Counselors (NSGC).

Academic Appointments

Administrative Appointments

  • Co-Director, MS Program in Human Genetics and Genetic Counseling, Stanford University School of Medicine (2016 - Present)
  • Consultant on Genetic Counseling Professional Practice, Stanford Children's Health | Lucile Packard Children's Hospital (2016 - Present)

Boards, Advisory Committees, Professional Organizations

  • Board of Directors (Director at Large), National Society of Genetic Counselors (2015 - 2017)

Professional Education

  • EdD, Boston University, Educational Leadership and Policy (2015)
  • MS, University of South Carolina, Genetic Counseling (2000)
  • BS, Furman University, Psychology (1998)

Research & Scholarship

Current Research and Scholarly Interests

My research has focused on faculty development in academic medicine and the translation of genomics into public health.


2020-21 Courses

Stanford Advisees

  • Master's Program Advisor
    Jacqueline Fung, Wesley Ho, Helen Kim, Claire Murphy, Kathleen Murphy, Miles Picus, Callan Russell, Jennifer Siranosian, Caroline Stanclift


All Publications

  • Cancer genetic counselors' experiences with transgender patients: A qualitative study JOURNAL OF GENETIC COUNSELING Zayhowski, K., Park, J., Boehmer, U., Gabriel, C., Berro, T., Campion, M. 2019; 28 (3): 641?53

    View details for DOI 10.1002/jgc4.1092

    View details for Web of Science ID 000472673100013

  • Genomic education for the next generation of health-care providers. Genetics in medicine : official journal of the American College of Medical Genetics Campion, M., Goldgar, C., Hopkin, R. J., Prows, C. A., Dasgupta, S. 2019


    Historically, medical geneticists and genetic counselors have provided the majority of genetic services. Advances in technology, reduction in testing costs, and increased public awareness have led to a growing demand for genetic services in both clinical and direct-to-consumer spaces. Recent and anticipated changes in the workforce of genetic counselors and medical geneticists require a reexamination of the way we educate health-care providers and the means by which we provide access to genetic services. The time is ripe for rapid growth of genetic and genomic services, but to capitalize on these opportunities, we need to consider a variety of educational mechanisms to reach providers both within and beyond the traditional genetic counseling and medical genetics sectors, including nurses, physician assistants, and nongenetics physicians. This article summarizes the educational efforts underway in each of these professions.

    View details for DOI 10.1038/s41436-019-0548-4

    View details for PubMedID 31110330

  • Cancer genetic counselors' experiences with transgender patients: A qualitative study. Journal of genetic counseling Zayhowski, K., Park, J., Boehmer, U., Gabriel, C., Berro, T., Campion, M. 2019


    It is becoming increasingly common for people to openly identify as transgender, yet there is little research in the field of genetic counseling regarding this community's unique medical needs. Transgender patients are likely to present with issues that cross genetics and gender-related care in a cancer genetic counseling session, and empiric data about these differences is needed to provide adequate care. In order to investigate what specific health topics and concerns are addressed in cancer genetic counseling sessions with transgender patients, 21 cancer genetic counselors who have seen transgender patients were interviewed. Through inductive analysis, six themes emerged: (1) documentation systems are not inclusive or clear; (2) genetic counselors feel unprepared for these sessions; (3) gender affirming hormones impact risk assessment; (4) genetic testing affects gender affirming surgical decisions; (5) transgender patients present at younger ages to clinic; and (6) pathogenic variants allow for insurance coverage for gender affirming surgeries. This study's findings point to opportunities for the field of genetic counseling to enhance services for transgender patients by reporting distinctive situations that may arise in clinic with these patients and providing training recommendations for genetic counselors.

    View details for PubMedID 30720922

  • MA number not sure JK9 CHALLENGES TO USING WEB-BASED FAMILY HISTORY TOOLS AMONG VULNERABLE PATIENT POPULATIONS Wang, C., Bickmore, T., Paasche-Orlow, M., Cunningham, T., Cabral, H., Winter, M., Campion, M., Bowen, D. OXFORD UNIV PRESS INC. 2018: S146
  • Genetic counselor training for the next generation: Where do we go from here? AMERICAN JOURNAL OF MEDICAL GENETICS PART C-SEMINARS IN MEDICAL GENETICS Riconda, D., Grubs, R. E., Campion, M. W., Cragun, D. 2018; 178 (1): 38?45

    View details for PubMedID 29512933

  • Experiences of Genetic Counselors Practicing in Rural Areas JOURNAL OF GENETIC COUNSELING Emmet, M., Stein, Q., Thorpe, E., Campion, M. 2018; 27 (1): 140?54


    In-person genetic counseling clinics in rural areas are likely to improve access to genetic counseling in underserved regions, but studies have not previously examined how these clinics function or described the experience of practicing in a rural setting. The present mixed-methods study explored the professional experiences of clinical genetic counselors who practice in rural areas, including the benefits and challenges of practicing in these settings and the counselors' motivations for doing so. The authors surveyed 20 genetic counselors who self-reported working in rural areas and conducted interviews with six individuals whose workplaces were confirmed as rural per RUCA code. Major obstacles to the provision of genetics services in rural areas included travel distance and low referral rates due to lack of awareness or skepticism. Facilitating factors included relying on resources such as professional networks and prioritizing outreach and education. Participants reported high professional satisfaction and were motivated to work in rural areas by personal experiences and qualities of the job such as being a generalist and having greater professional autonomy. These data demonstrate the feasibility of practicing in rural settings and suggest that in-person rural genetic counseling clinics may complement other strategies such as alternative service delivery models in increasing access for rural residents.

    View details for PubMedID 28831644

  • Mid-career faculty development in academic medicine: How does it impact faculty and institutional vitality? The journal of faculty development Campion, M. W., Bhasin, R. M., Beaudette, D. J., Shann, M. H., Benjamin, E. J. 2016; 30 (3): 49-64


    Faculty vitality is integral to the advancement of higher education. Strengthening vitality is particularly important for mid-career faculty, who represent the largest and most dissatisfied segment. The demands of academic medicine appear to be another factor that may put faculty at risk of attrition. To address these issues, we initiated a ten-month mid-career faculty development program.A mixed-methods quasi-experimental design was used to evaluate the program's impact on faculty and institutional vitality. Pre/post surveys compared participants with a matched reference group. Quantitative data were augmented by interviews and focus groups with multiple stakeholders.At the program's conclusion, participants showed statistically significant gains in knowledge, skills, attitudes, and connectivity when compared to the referents.Given that mid-career faculty development in academic medicine has not been extensively studied, our evaluation provides a useful perspective to guide future initiatives aimed at enhancing the vitality and leadership capacity of mid-career faculty.

    View details for PubMedID 27942418

  • Emerging Genetic Counselor Roles within the Biotechnology and Pharmaceutical Industries: as Industry Interest Grows in Rare Genetic Disorders, How are Genetic Counselors Joining the Discussion? Journal of genetic counseling Field, T., Brewster, S. J., Towne, M., Campion, M. W. 2016; 25 (4): 708?19


    Traditionally, the biotechnology and pharmaceutical industry (BPI) has focused drug development at the mass-market level targeting common medical issues. However, a recent trend is the development of therapies for orphan or rare disorders, including many genetic disorders. Developing treatments for genetic disorders requires an understanding of the needs of the community and translating genomic information to clinical and non-clinical audiences. The core skills of genetic counselors (GCs) include a deep knowledge of genetics and ability to communicate complex information to a broad audience, making GCs a choice fit for this shift in drug development. To date there is limited data defining the roles GCs hold within this industry. This exploratory study aimed to define the roles and motivation of GCs working in BPI, assess job satisfaction, and identify translatable skills and current gaps in GC training programs. The authors surveyed 26 GCs working in BPI in the United States; 79 % work for companies focused on rare disorders. GC positions in BPI are growing, with 57 % of respondents being the first GC in their role. GCs in BPI continue to utilize core genetic counseling competencies, though 72 % felt their training did not fully prepare them for BPI. These data suggest opportunities for exposure to BPI in GC training to better prepare future generations of GCs for these career opportunities. GC satisfaction was high in BPI, notably in areas traditionally reported as less satisfying on the National Society for Genetic Counselors Professional Status Survey: salary and advancement opportunities. BPI's growing interest in rare disorders represents a career opportunity for GCs, addressing both historic areas of dissatisfaction for GCs and BPI's genomic communication needs.

    View details for DOI 10.1007/s10897-016-9946-9

    View details for PubMedID 27017827

  • Confirmed versus suspected: The social significance of a genetic or non-genetic diagnosis of mitochondrial disease. Mitochondrion Krieg, E., Calderwood, L., Campion, M., Krepkovich, K. E. 2016; 28: 60?66


    This study assessed attitudes and beliefs regarding the importance of a genetic versus non-genetic diagnosis within the mitochondrial disease community. Survey respondents were categorized into two groups - those with a genetic diagnosis, and those with a non-genetic diagnosis of mitochondrial disease. We found that while both groups perceive problems with the support available to adult mitochondrial disease patients, the non-genetic group experiences less medical and social support due to lack of a definitive diagnosis. Understanding the efficacy of existing resources for mitochondrial disease sub-groups will allow for the development or improvement of resources designed to meet patient needs.

    View details for DOI 10.1016/j.mito.2016.03.008

    View details for PubMedID 27017995

  • Acceptability and feasibility of a virtual counselor (VICKY) to collect family health histories GENETICS IN MEDICINE Wang, C., Bickmore, T., Bowen, D. J., Norkunas, T., Campion, M., Cabral, H., Winter, M., Paasche-Orlow, M. 2015; 17 (10): 822-830


    To overcome literacy-related barriers in the collection of electronic family health histories, we developed an animated Virtual Counselor for Knowing your Family History, or VICKY. This study examined the acceptability and accuracy of using VICKY to collect family histories from underserved patients as compared with My Family Health Portrait (MFHP).Participants were recruited from a patient registry at a safety net hospital and randomized to use either VICKY or MFHP. Accuracy was determined by comparing tool-collected histories with those obtained by a genetic counselor.A total of 70 participants completed this study. Participants rated VICKY as easy to use (91%) and easy to follow (92%), would recommend VICKY to others (83%), and were highly satisfied (77%). VICKY identified 86% of first-degree relatives and 42% of second-degree relatives; combined accuracy was 55%. As compared with MFHP, VICKY identified a greater number of health conditions overall (49% with VICKY vs. 31% with MFHP; incidence rate ratio (IRR): 1.59; 95% confidence interval (95% CI): 1.13-2.25; P = 0.008), in particular, hypertension (47 vs. 15%; IRR: 3.18; 95% CI: 1.66-6.10; P = 0.001) and type 2 diabetes (54 vs. 22%; IRR: 2.47; 95% CI: 1.33-4.60; P = 0.004).These results demonstrate that technological support for documenting family history risks can be highly accepted, feasible, and effective.

    View details for DOI 10.1038/gim.2014.198

    View details for Web of Science ID 000362441900011

    View details for PubMedID 25590980

  • NSGC Practice Guideline: Prenatal Screening and Diagnostic Testing Options for Chromosome Aneuploidy JOURNAL OF GENETIC COUNSELING Wilson, K. L., Czerwinski, J. L., Hoskovec, J. M., Noblin, S. J., Sullivan, C. M., Harbison, A., Campion, M. W., Devary, K., Devers, P., Singletary, C. N. 2013; 22 (1): 4-15


    The BUN and FASTER studies, two prospective multicenter trials in the United States, validated the accuracy and detection rates of first and second trimester screening previously reported abroad. These studies, coupled with the 2007 release of the American College of Obstetricians and Gynecologists (ACOG) Practice Bulletin that endorsed first trimester screening as an alternative to traditional second trimester multiple marker screening, led to an explosion of screening options available to pregnant women. ACOG also recommended that invasive diagnostic testing for chromosome aneuploidy be made available to all women regardless of maternal age. More recently, another option known as Non-invasive Prenatal Testing (NIPT) became available to screen for chromosome aneuploidy. While screening and testing options may be limited due to a variety of factors, healthcare providers need to be aware of the options in their area in order to provide their patients with accurate and reliable information. If not presented clearly, patients may feel overwhelmed at the number of choices available. The following guideline includes recommendations for healthcare providers regarding which screening or diagnostic test should be offered based on availability, insurance coverage, and timing of a patient's entry into prenatal care, as well as a triage assessment so that a general process can be adapted to unique situations.

    View details for DOI 10.1007/s10897-012-9545-3

    View details for Web of Science ID 000314028900002

    View details for PubMedID 23179172

  • Zen and the Art of Program Development JOURNAL OF GENETIC COUNSELING Campion, M. 2012; 21 (2): 179-180

    View details for DOI 10.1007/s10897-011-9440-3

    View details for Web of Science ID 000303890000008

    View details for PubMedID 22127474

  • Transition to the Clinical Doctorate: Attitudes of the Genetic Counseling Training Program Directors in North America JOURNAL OF GENETIC COUNSELING Stuenkel, A. J., Campion, M., Allain, D., Hampel, H. 2012; 21 (1): 136-149


    In North America, genetic counseling is an allied health profession where entry level practitioners currently must hold a master's degree earned from a graduate program accredited by the American Board of Genetic Counseling. This is one of many health care professions that could transition to an entry level clinical doctorate degree. This study explored the attitudes of genetic counseling training program directors toward such a transition. Thirty-one North American program directors were invited to complete an online survey and a follow-up telephone interview. Twenty-one program directors completed the survey and ten directors also completed a follow up phone interview. There was disagreement among the respondents on the issue of transitioning to a clinical doctorate degree (nine in favor, six against and six undecided). Respondents disagreed about whether the transition would lead to higher salaries (six yes, eight no, and seven unsure) or increased professional recognition (eight yes, eight no, and four unsure). Approximately half (n?=?10) of directors were not sure if the transition to a clinical doctorate would help or hurt minority recruitment; six thought it would help and four thought it would hurt. However, the majority (n?=?13) thought a clinical doctorate would help genetic counselors to obtain faculty positions. If the field transitions to a clinical doctorate, 11 of the directors thought their program would convert, seven were unsure and one thought their program would shut down. Themes identified in interview data included 1) implications for the profession 2) institution-specific considerations and 3) perception of the unknown. Opinions are quite varied at this time regarding the possible transition to the clinical doctorate among genetic counseling training program directors.

    View details for DOI 10.1007/s10897-011-9407-4

    View details for Web of Science ID 000303889000017

    View details for PubMedID 21892706

Footer Links:

Stanford Medicine Resources: